VIDEO: Heinrich Questions FDA Commissioner on Avian Flu, Infant Formula Supply, Illicit Vaping Products, and Mifepristone
May 08, 2024
May 08, 2024
WASHINGTON, May 8 -- Sen. Martin Heinrich, D-New Mexico, issued the following news release:
Today during a hearing to review the Fiscal Year 2025 (FY25) Budget Request for the Food and Drug Administration (FDA), U.S. Senator Martin Heinrich (D-N.M.), Chairman of the Senate Appropriations Subcommittee that oversees funding for the FDA, urged FDA Commissioner Dr. Robert Califf to prioritize preparation for virus threats from livestock, inspections at infant formula facilities, and add . . .
Today during a hearing to review the Fiscal Year 2025 (FY25) Budget Request for the Food and Drug Administration (FDA), U.S. Senator Martin Heinrich (D-N.M.), Chairman of the Senate Appropriations Subcommittee that oversees funding for the FDA, urged FDA Commissioner Dr. Robert Califf to prioritize preparation for virus threats from livestock, inspections at infant formula facilities, and add . . .